InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Poly(I:C) (HMW) VacciGrade™ | SETD5 modulates homeostasis of hematopoietic stem cells by mediating RNA Poly... | 2021 | Leukemia | Li M. et al. | DOI: 10.1038/s41375-021-01481-1 |
| Puromycin | Therapeutic potential of TRPM8 antagonists in prostate cancer. | 2021 | Sci Rep | Di Donato M. et al. | DOI: 10.1038/s41598-021-02675-4 |
| Zeocin® | Therapeutic potential of TRPM8 antagonists in prostate cancer. | 2021 | Sci Rep | Di Donato M. et al. | DOI: 10.1038/s41598-021-02675-4 |
| G418 (Geneticin) | Therapeutic potential of TRPM8 antagonists in prostate cancer. | 2021 | Sci Rep | Di Donato M. et al. | DOI: 10.1038/s41598-021-02675-4 |
| Pam3CSK4 | Neuropilin-2 regulates airway inflammation in a neutrophilic asthma model. | 2021 | Immun Inflamm Dis | Immormino R.M. et al. | DOI: 10.1002/iid3.575 |
| LPS-EB (LPS from E. coli O111:B4) | Neuropilin-2 regulates airway inflammation in a neutrophilic asthma model. | 2021 | Immun Inflamm Dis | Immormino R.M. et al. | DOI: 10.1002/iid3.575 |
| Alhydrogel® adjuvant 2% | A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination. | 2021 | Virology | Hu Z. et al. | DOI: 10.1016/j.virol.2021.11.011 |
| Poly(I:C) LMW | SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading... | 2021 | Cell Mol Immunol. | Li X. et al. | DOI: 10.1038/s41423-021-00807-4 |
| Puromycin | MLL1 is regulated by KSHV LANA and is important for virus latency. | 2021 | Nucleic Acids Res | Tan M. et al. | DOI: 10.1093/nar/gkab1094 |
| Puromycin | Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vi... | 2021 | EBioMedicine | Huang H.C. et al. | DOI: 10.1016/j.ebiom.2021.103712 |
| Plasmocure™ - Mycoplasma Elimination Reagent | Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Co... | 2021 | Clin Lab Anal | Hayashi K. et al. | DOI: 10.1002/jcla.24146 |
| MS4A1 | Block-Removed Immunoglobulin Technology to enhance rituximab effector functio... | 2021 | Oncol Lett | Grasso L. et al. | DOI: 10.3892/ol.2021.13120 |
| c-di-AMP VacciGrade™ | An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit... | 2021 | Vaccines (Basel) | Cao H. et al. | DOI: 10.3390/vaccines9111261 |
| ODN 2395 VacciGrade™ | An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit... | 2021 | Vaccines (Basel) | Cao H. et al. | DOI: 10.3390/vaccines9111261 |
| Poly(I:C) LMW | Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune re... | 2021 | Cancer Immunol Immunother | Hänel G. et al. | DOI: 10.1007/s00262-021-03109-w |
| R848 (Resiquimod) | Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune re... | 2021 | Cancer Immunol Immunother | Hänel G. et al. | DOI: 10.1007/s00262-021-03109-w |
| Normocin® - Antimicrobial Reagent | CAF promotes chemoresistance through NRP2 in gastric cancer. | 2021 | Gastric Cancer | Yang Y. et al. | DOI: 10.1007/s10120-021-01270-w |
| Zeocin® | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| QUANTI-Blue™ | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| QUANTI-Luc™: Luciferase Detection Reagent | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |